Where does Drug Delivery Co., LLC. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Drug Delivery Co., LLC. ranks #31,451 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Drug Delivery Co., LLC. hold?

Drug Delivery Co., LLC. holds 8 US utility patents granted between 2016 and 2024, spanning 8 technology areas.

What is Drug Delivery Co., LLC.'s Innovation Score?

Drug Delivery Co., LLC. has an Innovation Score of 26.1 out of 100 (19th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Drug Delivery Co., LLC.'s patent grant rate increasing or decreasing?

Drug Delivery Co., LLC.'s recent grant velocity is -40% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Drug Delivery Co., LLC.'s patents?

Drug Delivery Co., LLC.'s patents average 11.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Drug Delivery Co., LLC. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Drug Delivery Co., LLC.

Q: What technology areas does Drug Delivery Co., LLC. focus on?

Drug Delivery Co., LLC.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 6 patents, ranking #1,036 of 3,082 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 8 granted patents across 8 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Drug ranks #31,451 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 8 technology areas.

#31,451
of 49,997 US assignees by volume: 19th percentile
by Innovation Score (26.1/100): 11.4
avg claims per patent: -40%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R31451 · US Corporation #31,451 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #31,451/49,997
PHOTO-FINISH Dream Lion Internati…
CPC-NARROW A61F · 8 areas
INNOV-THIN 26.1/100
CLAIMS-PAR 11.4 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -40% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Dream Lion International Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Drug’s 26.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.6 pts (29%) Velocity 1.7 pts (7%) Breadth 10.0 pts (38%) Claim depth 6.8 pts (26%)

Qualcomm Incorporated · highest

85
Drug Delivery · this assignee

26
3D Lighting… · lowest

7

What this shows Drug's Innovation Score is 26.1/100 (19th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Drug?

Each dot is one of Drug’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Drug’s own 11.4 claims/patent is ABOVE the 6.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Drug vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Drug's grants concentrate

Drug Delivery Co., LLC. is a focused PatentsView assignee: 8 CPC subclasses with 75% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2016 (2 grants) versus a trough of 1 in 2018. By volume, Drug sits between Dream Lion International Limited and Dten, Inc..

Drug's three-year grant acceleration

Drug Delivery Co., LLC. shows 1 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Dream Lion Intern…

8
Dreamgear

8
DRK Blutspendedie…

8
Drtech

8
Drycode Gear

8
DSA International

8
Dsilo

8
Dten

8
Drug Delivery ◀

8

What this shows Drug holds 8 patents at rank #31,412, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Drug

By rank, the assignees closest to #31,412 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Drug's primary technology class.

Drug's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

26 19th percentile higher than 19% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Drug Delivery Co., LLC. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	25.0%
2018	1	12.5%
2019	2	25.0%
2021	2	25.0%
2024	1	12.5%

Which technologies does Drug Delivery Co., LLC. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 6

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

A61B - DIAGNOSIS; SURGERY; Identification 3

G02C - SPECTACLES; Sunglasses OR Goggles Insofar AS They Have THE Same Features AS SPECTACLES; Contact Lenses 3

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 2

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 2

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Drug Delivery Co., LLC.'s patent record in context - here's where to go next.

Drug Delivery Co., LLC.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 75% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #31,451 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Drug Delivery Co., LLC. against Dream Lion International Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 26.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.